Morphotek, a subsidiary of Eisai, and the Sandy Rollman Ovarian Cancer Foundation (SROCF) have announced the launch of a resource to educate ovarian cancer patients and caregivers on clinical trials. Morphotek and SROCF collaborated on "Clinical Trials: A Start" after conducting a patient and caregiver roundtable on general barriers to clinical trial participation. It was evident during the roundtable that more needed to be done to demystify the complex topic of clinical trials and help patients and caregivers better understand this potential option. "Clinical Trials: A Start" is intended to address many of the questions and concerns raised by the roundtable participants. While it is not possible to address every question or possible clinical trial design in an educational brochure, we hope that this resource serves as a meaningful start for patients and caregivers.

Morphotek and SROCF are grateful to the women who participated in the roundtable and who helped to develop this educational resource. “Clinical Trials: A Start” is available for free download on SROCF's and Morphotek's websites.

“In light of our hhc Mission, we welcomed this opportunity to collaborate with the Sandy Rollman Ovarian Cancer Foundation to educate patients and caregivers on the often complex subject of clinical trials,” said Nicholas Nicolaides, President and chief executive officer of Morphotek. “We hope that ‘Clinical Trials: A Start’ proves to be an easy-to-understand resource that helps patients to have a more meaningful discussion with their healthcare provider on clinical trials.”

“We’re hopeful that this brochure might serve as a starting point for women fighting ovarian cancer to learn about potentially lifesaving clinical trials,” said Robin Cohen, co-founder and chief executive officer of the Sandy Rollman Ovarian Cancer Foundation. “Many women are unaware of or confused by the options available to them, and we hope to change that.”